Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Spencer

Showing results (11-20 of 107) with videos related to

Pageof 11
Sort By:
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 19, 2006
Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHDEric Mick, Joseph Biederman, Thomas Spencer, et al.
Computational Biology and Chemistry|December 3, 2005
Statistical models in assessing fold change of gene expression in real-time RT-PCR experimentsWenjiang J Fu, Jianbo Hu, Thomas Spencer, et al.
Journal of Clinical Psychopharmacology|January 8, 2004
Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorderStephen V Faraone, Thomas Spencer, Megan Aleardi, et al.
CNS Neuroscience & Therapeutics|November 11, 2011
Is response to OROS-methylphenidate treatment moderated by treatment with antidepressants or psychiatric comorbidity? A secondary analysis from a large randomized double blind study of adults with ADHDJoseph Biederman, Eric Mick, Thomas Spencer, et al.
Journal of Attention Disorders|February 17, 2009
Long-term effectiveness and safety of dexmethylphenidate extended-release capsules in adult ADHDLenard A Adler, Thomas Spencer, James J McGough, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|September 22, 2005
ADHD treatment with once-daily OROS methylphenidate: final results from a long-term open-label studyTimothy Wilens, Keith McBurnett, Mark Stein, et al.
Journal of Child and Adolescent Psychopharmacology|August 21, 2004
Emergence of tics in children with ADHD: impact of once-daily OROS methylphenidate therapyDonna Palumbo, Thomas Spencer, Joseph Lynch, et al.
Bipolar Disorders|December 14, 2007
A prospective open-label treatment trial of ziprasidone monotherapy in children and adolescents with bipolar disorderJoseph Biederman, Eric Mick, Thomas Spencer, et al.
Journal of Attention Disorders|October 16, 2007
Assessing the validity of the Quality of Life Enjoyment and Satisfaction Questionnaire Short Form in adults with ADHDEric Mick, Stephen V Faraone, Thomas Spencer, et al.
Pediatrics|July 1, 2009
Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up studyJoseph Biederman, Michael C Monuteaux, Thomas Spencer, et al.
Pageof 11

Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 19, 2006
Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHDEric Mick, Joseph Biederman, Thomas Spencer, et al.
Computational Biology and Chemistry|December 3, 2005
Statistical models in assessing fold change of gene expression in real-time RT-PCR experimentsWenjiang J Fu, Jianbo Hu, Thomas Spencer, et al.
Journal of Clinical Psychopharmacology|January 8, 2004
Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorderStephen V Faraone, Thomas Spencer, Megan Aleardi, et al.
CNS Neuroscience & Therapeutics|November 11, 2011
Is response to OROS-methylphenidate treatment moderated by treatment with antidepressants or psychiatric comorbidity? A secondary analysis from a large randomized double blind study of adults with ADHDJoseph Biederman, Eric Mick, Thomas Spencer, et al.
Journal of Attention Disorders|February 17, 2009
Long-term effectiveness and safety of dexmethylphenidate extended-release capsules in adult ADHDLenard A Adler, Thomas Spencer, James J McGough, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|September 22, 2005
ADHD treatment with once-daily OROS methylphenidate: final results from a long-term open-label studyTimothy Wilens, Keith McBurnett, Mark Stein, et al.
Journal of Child and Adolescent Psychopharmacology|August 21, 2004
Emergence of tics in children with ADHD: impact of once-daily OROS methylphenidate therapyDonna Palumbo, Thomas Spencer, Joseph Lynch, et al.
Bipolar Disorders|December 14, 2007
A prospective open-label treatment trial of ziprasidone monotherapy in children and adolescents with bipolar disorderJoseph Biederman, Eric Mick, Thomas Spencer, et al.
Journal of Attention Disorders|October 16, 2007
Assessing the validity of the Quality of Life Enjoyment and Satisfaction Questionnaire Short Form in adults with ADHDEric Mick, Stephen V Faraone, Thomas Spencer, et al.
Pediatrics|July 1, 2009
Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up studyJoseph Biederman, Michael C Monuteaux, Thomas Spencer, et al.
Pageof 11